CA
TMO icon

Continuum Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Continuum Advisory’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.21M Sell
2,459
-10
-0.4% -$5.43K 0.12% 167
2025
Q4 		$1.43M Buy
2,469
+310
+14% +$175K 0.14% 135
2025
Q3 		$1.05M Sell
2,159
-69
-3% -$32.1K 0.11% 173
2025
Q2 		$903K Buy
2,228
+182
+9% +$76.1K 0.11% 177
2025
Q1 		$1.02M Sell
2,046
-178
-8% -$96.4K 0.13% 149
2024
Q4 		$1.16M Sell
2,224
-10
-0.4% -$5.5K 0.15% 138
2024
Q3 		$1.19M Sell
2,234
-17
-0.8% -$10.1K 0.15% 144
2024
Q2 		$1.24M Sell
2,251
-6
-0.3% -$3.44K 0.18% 126
2024
Q1 		$1.3M Sell
2,257
-45
-2% -$25.3K 0.2% 119
2023
Q4 		$1.22M Sell
2,302
-203
-8% -$98.3K 0.17% 148
2023
Q3 		$1.27M Sell
2,505
-27
-1% -$14.4K 0.2% 137
2023
Q2 		$1.32M Buy
2,532
+1
+0% +$540 0.21% 134
2023
Q1 		$1.46M Sell
2,531
-194
-7% -$109K 0.25% 116
2022
Q4 		$1.5M Sell
2,725
-142
-5% -$75.2K 0.27% 109
2022
Q3 		$1.45M Buy
2,867
+91
+3% +$50.9K 0.26% 102
2022
Q2 		$1.51M Buy
2,776
+32
+1% +$17.6K 0.27% 104
2022
Q1 		$1.52M Buy
2,744
+920
+50% +$528K 0.29% 97
2021
Q4 		$1.22M Sell
1,824
-59
-3% -$36.8K 0.27% 91
2021
Q3 		$1.08M Buy
1,883
+54
+3% +$29.6K 0.29% 91
2021
Q2 		$923K Buy
+1,829
New +$863K 0.29% 90
2018
Q1 		– Sell
-1,483
Closed -$282K – 173
2017
Q4 		$282K Buy
1,483
+80
+6% +$15.3K 0.22% 118
2017
Q3 		$265K Buy
1,403
+115
+9% +$20.8K 0.23% 118
2017
Q2 		$225K Buy
+1,288
New +$216K 0.22% 128

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Continuum Advisory's TMO Position: Q1 2026 in Review

Continuum Advisory reduced its Thermo Fisher Scientific (TMO) stake by 0.41% in Q1 2026, selling an estimated $5.43K and leaving 2,459 shares worth $1.21M. The position accounts for 0.12% of the portfolio, ranked #167.

Continuum Advisory first reported a position in TMO in Q2 2017 and has held it in 23 quarters since. The position peaked at $1.52M in Q1 2022. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Continuum Advisory held 2,459 shares of Thermo Fisher Scientific worth $1.21M as of Q1 2026.
  • Continuum Advisory sold 10 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.43K.
  • Thermo Fisher Scientific made up 0.12% of Continuum Advisory's portfolio in Q1 2026, its #167 holding.
  • Continuum Advisory first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 23 quarters since.
  • Continuum Advisory's Thermo Fisher Scientific position peaked at $1.52M in Q1 2022.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Continuum Advisory's 13F filing for Q1 2026, filed 22 Apr 2026.